Your Blood Tests Are Normal.
Why Are You Still Tired?

People use the same word for several different experiences. A person who fights sleep at a red light has a different problem from someone who is alert but cannot produce normal force in the gym. A runner whose breathing has changed has a different problem from someone who feels drained for a day after modest activity. The distinction directs the next questions.^[1][3]

Time course matters. Fatigue after a deliberate overload week is not interpreted like an abrupt decline without a training change. Symptoms present on waking suggest a different set of questions from a predictable mid-afternoon crash. Post-exertional malaise—disproportionate symptom worsening after activity, often delayed—deserves explicit attention because a generic “push through it” plan can be inappropriate.^[1][17]

Bring examples rather than only a severity score: “I sleep nine hours but nod off in meetings,” “my squat is down 12% across three weeks,” or “a normal session produces a two-day crash.” Those descriptions create testable hypotheses.

A laboratory reference interval generally describes where most results fall in a defined reference population using that laboratory’s method. A clinical decision threshold answers a different question: at what value does a particular diagnosis, risk or treatment discussion become more likely? Your previous stable value is a third kind of information. These three numbers can coincide, but they do not have to.

Test timing and physiology can move results. Training, acute illness, hydration, menstrual blood loss, food intake, time of day and recent medication or PED changes may all matter for selected analytes. One normal result also cannot answer an unasked question. A complete blood count can make anemia less likely, but it does not measure sleep apnea. A normal TSH does not evaluate every cause of low motivation. A normal creatinine does not grade training recovery.

At the same time, expanding the panel without a hypothesis creates opportunities for incidental abnormalities. A 2023 primary-care guideline recommends history, examination and a limited basic laboratory evaluation, with further tests driven by specific indications. The point is not to minimize symptoms. It is to improve the chance that an abnormality explains them.^[1][2]

Sleep can fail while eight hours still appear on the clock

Time in bed is not the same as restorative sleep. Sleep apnea can present with daytime sleepiness, fatigue, headaches, insomnia, sexual symptoms, gasping or frequent urination at night; not every patient fits the stereotype. A consumer wearable is not a diagnostic exclusion test. When symptoms and risk make apnea plausible, clinical assessment determines whether polysomnography or an appropriate home sleep-apnea test is warranted.^[3][4]

Sleep opportunity also matters. A person who needs eight hours but repeatedly obtains six does not require an exotic explanation for the resulting impairment. Shift work, irregular sleep timing, late stimulant exposure and a bedroom schedule incompatible with the body clock will not appear on a metabolic panel. The related sleep-stack evidence guide separates falling asleep from staying asleep and next-day function.

Medication and substance effects are easy to normalize

Sedating antihistamines, some pain medicines, sleep drugs, some psychiatric drugs, alcohol and cannabis can contribute to fatigue or sleepiness. Stimulants may temporarily mask sleep debt and then complicate timing. A PED audience should also include compounds, ancillaries, recent dose changes and withdrawal periods in the exposure history. The relevant question is not whether a product is usually described as energizing; it is whether the timing of symptoms tracks the actual exposure.

Do not stop a prescription abruptly because fatigue is listed as a possible effect. Build one dated list—prescriptions, over-the-counter products, supplements, caffeine, nicotine, alcohol and performance compounds—and review it with the clinician who can weigh the reason each item is being used.

Mood and cognition are biological context, not a dismissal

Depression and anxiety can cause or amplify fatigue, sleep disruption and cognitive slowing. Chronic pain and psychosocial stress can do the same. Screening for them does not mean “it is all in your head”; it means the brain and body are part of one system. Conversely, a mood score should not be used to ignore new objective weakness, fever, bleeding or other physical warning signs.^[1][2]

Training deliberately creates fatigue. Adaptation requires enough recovery and fuel to absorb it. The ECSS/ACSM consensus distinguishes short-term functional overreaching from prolonged maladaptation, but also emphasizes that no single hormone, immune marker, heart-rate value or biochemical test diagnoses overtraining syndrome. It remains a clinical exclusion problem supported by the training history and performance trajectory.^[12]

Low energy availability means too little energy remains for normal physiology after exercise costs are accounted for. It can be intentional or accidental and can affect women and men. Fatigue, impaired training response, recurrent injury or illness, menstrual disturbance, reduced libido and bone-health concerns can cluster, but no one symptom proves Relative Energy Deficiency in Sport. The 2023 IOC statement uses a multi-indicator clinical assessment, not one “REDs blood test.”^[13]

A practical deload can be informative when it is safe: did performance and energy rebound when training stress fell and food and sleep were restored? That observation is not a substitute for evaluation when symptoms are severe, progressive or accompanied by red flags. It simply turns the training log into clinically useful context.

PED use can alter both the symptom and the panel

Androgens and other performance compounds can shift hematocrit, blood pressure, lipids, liver-associated enzymes, reproductive hormones and sleep-disordered breathing risk. Interpreting a panel without the compound, route, timing and recent changes can be misleading. A value taken mid-cycle may answer a different question from one taken after cessation.

Fatigue alone is also a poor reason to assume testosterone deficiency. The Endocrine Society recommends diagnosing hypogonadism only when compatible symptoms or signs coexist with unequivocally and consistently low testosterone, confirmed with repeat morning fasting measurement and an evaluation of cause.^[11]

Iron can matter before hemoglobin crosses the anemia threshold

Iron deficiency without anemia is a useful example of why the exact question matters. A 2018 systematic review included 18 trials and 1,170 non-anemic iron-deficient adults. Across four trials with fatigue outcomes, iron reduced subjective fatigue (standardized mean difference −0.38, 95% CI −0.52 to −0.23). Across nine trials, it did not significantly improve maximal oxygen consumption (SMD 0.11, 95% CI −0.15 to 0.37). Feeling better and measuring better exercise capacity were not the same endpoint.^[5]

In one randomized trial, 198 menstruating women with fatigue, hemoglobin above 12.0 g/dL and ferritin below 50 μg/L received 80 mg elemental iron daily or placebo for 12 weeks. Fatigue fell 47.7% with iron and 28.8% with placebo; the between-group difference was −18.9 percentage points (95% CI −34.5 to −3.2). Quality of life, depression and anxiety did not significantly differ. That population and threshold should not be converted into a universal prescription: excess iron is not an energy enhancer, and the reason for deficiency matters.^[6]

Vitamin D: a positive trial in people who were deficient

A double-blind trial enrolled 120 otherwise healthy adults reporting fatigue with 25-hydroxyvitamin D below 20 μg/L. A single 100,000-IU oral dose of vitamin D3 produced a larger four-week fall in Fatigue Assessment Scale score than placebo: −3.3 versus −0.8 points (P=.01). Seventy-two percent versus 50% reported improvement (odds ratio 2.63, 95% CI 1.23–5.62). This supports correcting documented deficiency; it does not show that pushing an already sufficient level higher improves energy.^[7]

B12 and thyroid tests need context, too

Vitamin B12 deficiency can cause fatigue and neurologic symptoms even without anemia. Serum B12 is usually the first marker; the NIH fact sheet notes that methylmalonic acid can help confirm suspected deficiency when B12 is borderline, while kidney function can also raise MMA. Risk is higher with malabsorption, gastrointestinal surgery, pernicious anemia, vegetarian or vegan diets without adequate fortified intake, and prolonged use of selected medications such as metformin or proton-pump inhibitors.^[8]

On the other side of the optimization argument, lowering a mildly elevated TSH into range does not guarantee symptom improvement. A meta-analysis of 21 randomized trials involving 2,192 adults with subclinical hypothyroidism found no significant improvement in general quality of life or thyroid-related symptoms with thyroid hormone. Fatigue/tiredness also did not improve overall. Most trials involved mild TSH elevation, so the result should not be generalized to overt hypothyroidism, pregnancy or every severe presentation.^[9]

A mechanistic story can be true without solving nonspecific fatigue. Testosterone increases androgen-receptor signaling; creatine supports phosphocreatine energy buffering; NAD precursors alter redox-related metabolites. The clinical question is still whether the tested person felt or functioned better than the control group.

In the Testosterone Trials, 790 men aged 65 or older had symptoms and repeatedly low testosterone. Testosterone gel did not significantly improve the prespecified vitality response on the FACIT–Fatigue scale (odds ratio 1.23, P=.30), although some secondary mood and symptom measures showed small changes. That is not a trial in younger eugonadal athletes, but it is a warning against treating fatigue as proof that more testosterone is the missing input.^[10]

A 2024 crossover experiment in 15 healthy people used a single creatine dose of 0.35 g/kg during one night of sleep deprivation. Brain high-energy phosphate measures and selected cognitive tasks improved relative to placebo over the following hours. It is a provocative stress-state result, not evidence for taking that unusually large dose to treat persistent unexplained fatigue, and it does not demonstrate restored sleep physiology.^[14]

NAD research shows the same gap. In 12 older men, 1 g/day nicotinamide riboside for 21 days increased whole-blood NAD, while muscle NAD+, mitochondrial bioenergetics and handgrip did not clearly improve. A later 58-person long-COVID trial reported large NAD increases but no significant between-group advantage for fatigue, sleep, mood or cognition. Interesting mechanisms remain worth studying; the current human outcomes do not support using a biomarker rise as proof of restored energy.^[15][16]

The pattern is not “supplements never work.” It is that correction works best when a correctable problem has been identified, and enhancement claims require trials in people resembling the intended user. Otherwise, a new compound can blur the symptom while the original cause remains.

Bring a timeline, not a shopping list

Record when symptoms began, whether they followed infection, travel, a cut, a training block, a medication change or a PED transition, and what happens after exertion. Add sleep opportunity, witnessed snoring or gasping, menstrual bleeding where relevant, dietary restriction, weight change and a performance trend. Include the exact tests already completed with dates, units and laboratory intervals.

Ask which hypotheses are now less likely and which remain plausible. Targeted additions might include iron studies, B12 with confirmatory markers, pregnancy testing, infectious or inflammatory evaluation, sleep testing, or endocrine assessment—but only when the history and examination support them. “Can we order everything?” is less useful than “What result would change the plan?”^{[1][2][4][8][11]}

The conclusion: a normal result is information, not closure

Routine labs are valuable because they can identify anemia, thyroid disease, glucose abnormalities, organ dysfunction and other important problems. When they are unrevealing, the answer is not that nothing is wrong—and it is not automatically that an “optimal” hormone or mitochondrial compound is missing.

Define the symptom. Reconstruct the timeline. Audit sleep, substances, medications, training and fuel. Correct documented deficiencies at the level the evidence supports. Use targeted testing to answer the next most plausible question. The goal is not a perfect panel. It is to restore function without mistaking more data—or more compounds—for a diagnosis.